NextBio raises $8M

NextBio has closed a $8 million Series C round of financing led by Newbury Ventures, a previous investor, and including participation from prominent private investors. The capital will be help the company grow its sales reach and channels, as well as international expansion. NextBio provide a platform that lets life science researchers search and share information within public and proprietary data. Release

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.